1 United Nations (2009) .
2 Reid, LM & MacLullich, AMJ (2006) Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord 22, 471–485.
3 Ferri, CP, Prince, M, Brayne, C, et al. (2005) Global prevalence of dementia: a Delphi Consensus Study. Lancet 366, 2112–2117.
4 Mishra, S & Palanivelu, K (2008) The effect of curcumin (turmeric) on Alzheimer's disease: an overview. Ann Indian Acad Neurol 11, 13–19.
5 Zelinski, EM & Burnight, KP (1997) Sixteen-year longitudinal and time lag changes in memory and cognition in older adults. Psychol Aging 12, 503–513.
6 Schaie, KW (1996) .
7 Craik, FIM (1994) Memory changes in normal aging. Curr Dir Psychol Sci 3, 155–158.
8 Park, DC, Lautenschlager, G, Smith, AD, et al. (1996) Mediators of long-term memory performance across the life span. Psychol Aging 11, 621–637.
9 Park, DC, Lautenschlager, G, Hedden, T, et al. (2002) Models of visuospatial and verbal memory across the adult life span. Psychol Aging 17, 299–320.
10 Hultsch, DF, MacDonald, SWS & Dixon, RA (2002) Variability in reaction time performance of younger and older adults. J Gerontol B Psychol Sci Soc Sci 57, M228–M235.
11 Salthouse, TA (1996) The processing-speed theory of adult age differences in cognition. Psychol Rev 103, 403–428.
12 Rabbitt, P & Lowe, C (2000) Patterns of cognitive ageing. Psychol Res 63, 308–316.
13 Verhaeghen, P & Cerella, J (2002) Aging, executive control, and attention: a review of meta-analyses. Neurosci Biobehav Rev 26, 849–857.
14 Bugg, JM, Zook, NA, DeLosh, EL, et al. (2006) Age differences in fluid intelligence: contributions of general slowing and frontal decline. Brain Cogn 62, 9–16.
15 Schretlen, D, Pearlson, GD, Anthony, JC, et al. (2000) Elucidating the contributions of processing speed, executive ablility, and frontal lobe volume to normal age-related differences in fluid intelligence. J Int Neuropsychol Soc 6, 52–61.
16 Hedden, T & Gabrieli, JDE (2004) Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 5, 87–96.
17 Kramer, AF, Fabiani, M & Colcombe, SJ (2006) Contributions of cognitive neuroscience to the understanding of behaviour and aging. In Handbook of the Psychology of Aging, pp. 57–83 [Birren, JE and Schaie, KW, editors]. Burlington, MA: Elsevier Academic Press.
18 West, RL (1996) An application of prefrontal cortex function theory to cognitive aging. Psychol Bull 120, 272–292.
19 Fjell, AM & Walhovd, KB (2010) Structural brain changes in aging: courses, causes and cognitive consequences. Rev Neurosci 21, 187–221.
20 Gracy, RW, Talent, JM, Kong, Y, et al. (1999) Reactive oxygen species: the unavoidable environmental insult? Mutat Res 428, 17–22.
21 Calabrese, V, Mancuso, C, Calvani, M, et al. (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8, 766–775.
22 Haan, MN, Miller, JW, Aiello, AE, et al. (2007) Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 85, 511–517.
23 Zipp, F & Aktas, O (2006) The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci 29, 518–527.
24 Hynd, MR, Scott, HL & Dodd, PR (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 45, 583–595.
25 Rogers, JT & Lahiri, DK (2004) Metal and inflammatory targets for Alzheimer's disease. Curr Drug Targets 5, 535–551.
26 Kidd, PM (2005) Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. Altern Med Rev 10, 268–293.
27 Thibault, O, Porter, NM, Chen, KC, et al. (1998) Calcium dysregulation in neuronal aging and Alzheimer's disease: history and new directions. Cell Calcium 24, 417–433.
28 Craft, S & Watson, GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3, 169–178.
29 Kidd, PM (2008) Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Altern Med Rev 13, 85–115.
30 Selkoe, DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81, 741–766.
31 Hardy, J & Selkoe, DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353–356.
32 Wang, BS, Wang, H, Wei, ZH, et al. (2009) Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis. J Neural Transm 116, 457–465.
33 May, BH, Lit, M, Xue, CC, et al. (2009) Herbal medicine for dementia: a systematic review. Phytother Res 23, 447–459.
34 Jones, RW (2003) Have cholinergic therapies reached their clinical boundary in Alzheimer's disease? Int J Geriatr Psychiatry 18, Suppl. 1, S7–S13.
35 Raina, P, Santaguida, P, Ismaila, A, et al. (2008) Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 148, 379–397.
36 Van der Schyf, CJ, Gal, S, Geldenhuys, WJ, et al. (2006) Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases. Expert Opin Investig Drugs 15, 873–886.
37 Panza, F, Solfrizzi, V, Colacicco, AM, et al. (2004) Mediterranean diet and cognitive decline. Health Nutr 7, 959–963.
38 Solfrizzi, V, Panza, F & Capurso, A (2003) The role of diet in cognitive decline. J Neural Transm 110, 95–110.
39 Smith, PJ & Blumenthal, JA (2010) Diet and neurocognition: review of evidence and methodological considerations. Curr Aging Sci 3, 57–66.
40 Weaver, CM (2010) Role of dairy beverages in the diet. Physiol Behav 100, 63–66.
41 Keller, JN (2009) Special issue: reciprocal interactions between diet, metabolism, and the nervous system. Biochim Biophys Acta 1792, 393–394.
42 van Meijl, LEC & Mensink, RP (2010) Low-fat dairy consumption reduces systolic blood pressure, but does not improve other metabolic risk parameters in overweight and obese subjects. Nutr Metab Cardiovasc Dis .
43 Engberink, MF, Hendriksen, MAH, Schouten, EG, et al. (1883) Inverse association between dairy intake and hypertension: The Rotterdam Study. Am J Clin Nutr 89, 1877–1883.
44 Toledo, E, Delgado-Rodríguez, M, Estruch, R, et al. (2009) Low-fat dairy products and blood pressure: follow-up of 2290 older persons at high cardiovascular risk participating in the PREDIMED study. Br J Nutr 101, 59–67.
45 Engberink, MF, Geleijnse, JM, De Jong, N, et al. (2009) Dairy intake, blood pressure, and incident hypertension in a general Dutch population. J Nutr 139, 582–587.
46 Ünal, G, Akalin, AS & Akbulut, N (2008) Importance of dairy products in metabolic syndrome – cardiovascular disease, insulin resistance and diabetes, and hypertension (Part 2). Agro Food Ind HiTech 19, 32–34.
47 Elwood, PC, Givens, DI, Beswick, AD, et al. (2008) The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer. J Am Coll Nutr 27, 723S–734S.
48 Elwood, PC, Pickering, JE, Givens, DI, et al. (2010) The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 45, 925–939.
49 Van Der Pols, JC, Gunnell, D, Williams, GM, et al. (2009) Childhood dairy and calcium intake and cardiovascular mortality in adulthood: 65-year follow-up of the Boyd Orr cohort. Heart 95, 1600–1606.
50 Esmaillzadeh, A & Azadbakht, L (2010) Dairy consumption and circulating levels of inflammatory markers among Iranian women. Public Health Nutr 13, 1395–1402.
51 van Meijl, LEC & Mensink, RP (2010) Effects of low-fat dairy consumption on markers of low-grade systemic inflammation and endothelial function in overweight and obese subjects: an intervention study. Br J Nutr 104, 1523–1527.
52 Huncharek, M, Muscat, J & Kupelnick, B (2009) Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26 335 cases from 60 observational studies. Nutr Cancer 61, 47–69.
53 Pufulete, M (2008) Intake of dairy products and risk of colorectal neoplasia. Nutr Res Rev 21, 56–67.
54 Yamada, M, Kasagi, F, Sasaki, H, et al. (2003) Association between dementia and midlife risk factors: the radiation effects research foundation Adult Health Study. J Am Geriatr Soc 51, 410–414.
55 Huncharek, M, Muscat, J & Kupelnick, B (2008) Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26 769 cases from 45 observational studies. Nutr Cancer 60, 421–441.
56 Zock, PL (2006) Health problems associated with saturated and trans fatty acids intake. In Improving the Fat Content of Foods, pp. 3–24 [C Williams and J Buttriss, editors]. Boca Raton, FL: CRC Press.
57 Henderson, L, Gregory, J, Irving, K, et al. (2003) National diet and nutrition survey: adults aged 19 to 64 years. vol 2: Energy, Protein, Carbohydrate, Fat and Alcohol Intake. London: The Stationery Office.
58 Hulshof, KFAM, Van Erp-Baart, MA, Anttolainen, M, et al. (1999) Intake of fatty acids in Western Europe with emphasis on trans fatty acids: The TRANSFAIR study. Eur J Clin Nutr 53, 143–157.
59 Berner, LA (1993) Roundtable discussion on milkfat, dairy foods, and coronary heart disease risk. J Nutr 123, 1175–1184.
60 Aro, A, Antoine, JM, Pizzoferrato, L, et al. (1998) Trans fatty acids in dairy and meat products from 14 European countries: the TRANSFAIR study. J Food Compost Anal 11, 150–160.
61 Hu, FB, Stampfer, MJ, Manson, JE, et al. (1999) Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr 70, 1001–1008.
62 Givens, DI (2008) Session 4: challenges facing the food industry in innovating for health impact on CVD risk of modifying milk fat to decrease intake of SFA and increase intake of cis-MUFA. Proc Nutr Soc 67, 419–427.
63 Givens, DI (2010) Milk and meat in our diet: good or bad for health? Animal 4, 1941–1952.
64 Mensink, RP, Zock, PL, Kester, ADM, et al. (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146–1155.
65 Hu, FB, Stampfer, MJ, Manson, JE, et al. (1997) Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337, 1491–1499.
66 Willett, WC, Stampfer, MJ, Manson, JE, et al. (1993) Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341, 581–585.
67 Chardigny, JM, Destaillats, F, Malpuech-Brugère, C, et al. (2008) Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 87, 558–566.
68 Grundy, SM, Brewer, HB Jr, Cleeman, JI, et al. (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109, 433–438.
69 Pereira, MA, Jacobs, DR Jr, Van Horn, L, et al. (2002) Dairy consumption, obesity, and the insulin resistance syndrome in young adults: The CARDIA Study. J Am Med Assoc 287, 2081–2089.
70 McKeown, NM, Meigs, JB, Liu, S, et al. (2004) Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham offspring cohort. Diabetes Care 27, 538–546.
71 Nelson, GJ, Schmidt, PC & Kelley, DS (1995) Low-fat diets do not lower plasma cholesterol levels in healthy men compared to high-fat diets with similar fatty acid composition at constant caloric intake. Lipids 30, 969–976.
72 Pfeuffer, M & Schrezenmeir, J (2007) Milk and the metabolic syndrome. Obes Rev 8, 109–118.
73 Van Meijl, LEC, Vrolix, R & Mensink, RP (2008) Dairy product consumption and the metabolic syndrome. Nutr Res Rev 21, 148–157.
74 Nilsson, M, Stenberg, M, Frid, AH, et al. (2004) Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr 80, 1246–1253.
75 Nakamura, Y, Yamamoto, N, Sakai, K, et al. (1995) Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J Dairy Sci 78, 1253–1257.
76 McCarron, DA & Reusser, ME (2002) Hypertensive cardiovascular disease: risk reduction by dietary calcium and dairy foods. Sci Aliments 22, 415–421.
77 Nagaoka, S, Futamura, Y, Miwa, K, et al. (2001) Identification of novel hypocholesterolemic peptides derived from bovine milkβ-lactoglobulin. Biochem Biophys Res Commun 281, 11–17.
78 Denke, MA, Fox, MM & Schulte, MC (1993) Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 123, 1047–1053.
79 Yaffe, K (2007) Metabolic syndrome and cognitive decline. Curr Alzheimer Res 4, 123–126.
80 Yaffe, K, Kanaya, A, Lindquist, K, et al. (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. J Am Med Assoc 292, 2237–2242.
81 Launer, LJ, Masaki, K, Petrovitch, H, et al. (1851) The association between midlife blood pressure levels and late-life cognitive function: The Honolulu-Asia Aging Study. J Am Med Assoc 274, 1846–1851.
82 Qiu, C, Winblad, B & Fratiglioni, L (2005) The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4, 487–499.
83 Gregg, EW, Yaffe, K, Cauley, JA, et al. (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Intern Med 160, 174–180.
84 Yaffe, K, Blackwell, T, Kanaya, AM, et al. (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63, 658–663.
85 Moroney, JT, Tang, MX, Berglund, L, et al. (1999) Low-density lipoprotein cholesterol and the risk of dementia with stroke. J Am Med Assoc 282, 254–260.
86 Yaffe, K, Barrett-Connor, E, Lin, F, et al. (2002) Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 59, 378–384.
87 Whitmer, RA, Sidney, S, Selby, J, et al. (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64, 277–281.
88 Launer, LJ (2002) Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev 1, 61–77.
89 Yaffe, K, Lindquist, K, Penninx, EM, et al. (2003) Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61, 76–80.
90 Fewlass, DC, Noboa, K, Pi-Sunyer, FX, et al. (1878) Obesity-related leptin regulates Alzheimer's Aβ. FASEB J 18, 1870–1878.
91 Benoit, SC, Clegg, DJ, Seeley, RJ, et al. (2004) Insulin and leptin as adiposity signals. Recent Prog Horm Res 59, 267–285.
92 Luchsinger, JA, Tang, MX, Shea, S, et al. (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63, 1187–1192.
93 Luchsinger, JA, Tang, MX, Stern, Y, et al. (2001) Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154, 635–641.
94 Yaffe, K, Blackwell, T, Whitmer, RA, et al. (2006) Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging 10, 292–295.
95 American Diabetes Association (2001) Postprandial blood glucose (consensus statement). Diabetes Care 24, 775–778.
96 Polonsky, KS, Given, BD, Hirsch, LJ, et al. (1988) Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318, 1231–1239.
97 Pfeifer, MA, Halter, JB & Porte, D Jr (1981) Insulin secretion in diabetes mellitus. Am J Med 70, 579–588.
98 Del Prato, S, Leonetti, F, Simonson, DC, et al. (1994) Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 37, 1025–1035.
99 Craft, S, Murphy, C & Wemstrom, J (1994) Glucose effects on complex memory and nonmemory tasks: the influence of age, sex, and glucoregulatory response. Psychobiology (Austin, TX) 22, 95–105.
100 Owens, D & Benton, D (1994) The impact of raising blood glucose on reaction times. Neuropsychobiology 30, 106–113.
101 Donohoe, R & Benton, D (1999) Cognitive functioning is susceptible to the level of blood glucose. Psychopharmacology 145, 378–385.
102 Benton, D, Owens, D & Parker, P (1994) Blood glucose influences memory and attention in young adults. Neuropsychologia 32, 595.
103 Parker, P & Benton, D (1995) Blood glucose levels selectively influence memory for word lists dichotically presented to the right ear. Neuropsychologia 33, 843–854.
104 Clandinin, M, Cheema, S, Field, C, et al. (1993) Dietary lipids influence insulin action. Ann N Y Acad Sci 683, 151–163, .
105 Pan, J & Berdanier, C (1991) Dietary fat saturation affects glucose metabolism without affecting insulin receptor number and affinity in adipocytes from BHE rats. J Nutr 121, 1811.
106 Storlien, L, Higgins, J, Thomas, T, et al. (2007) Diet composition and insulin action in animal models. Br J Nutr 83, Suppl. 1, S85–S90.
107 Greenwood, C & Winocur, G (1996) Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty-acid intake. Behav Neurosci 110, 451–458.
108 Greenwood, C & Winocur, G (1990) Learning and memory impairment in rats fed a high saturated fat diet. Behav Neural Biol 53, 74–87.
109 Greenwood, C & Winocur, G (2001) Glucose treatment reduces memory deficits in young adult rats fed high-fat diets. Neurobiol Learn Mem 75, 179–189.
110 Messier, C, Tsiakas, M, Gagnon, M, et al. (2003) Effect of age and glucoregulation on cognitive performance. Neurobiol Aging 24, 985–1003.
111 Awad, N, Gagnon, M, Desrochers, A, et al. (2002) Impact of peripheral glucoregulation on memory. Behav Neurosci 116, 691–702.
112 Messier, C, Desrochers, A & Gagnon, M (1999) Effect of glucose, glucose regulation, and word imagery value on human memory. Behav Neurosci 113, 431–438.
113 Donohoe, R & Benton, D (2000) Glucose tolerance predicts performance on tests of memory and cognition Physiol Behav 71, 395–401.
114 Craft, S, Asthana, S, Schellenberg, G, et al. (2000) Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann N Y Acad Sci 903, 222–228.
115 Kaplan, R, Greenwood, C, Winocur, G, et al. (2000) Cognitive performance is associated with glucose regulation in healthy elderly persons and can be enhanced with glucose and dietary carbohydrates. Am J Clin Nutr 72, 825–836.
116 Manning, C, Hall, J & Gold, P (1990) Glucose effects on memory and other neuropsychological tests in elderly humans. Psychol Sci 1, 307–311.
117 Messier, C, Gagnon, M & Knott, V (1997) Effect of glucose and peripheral glucose regulation on memory in the elderly Neurobiol Aging 18, 297–304.
118 Parsons, M & Gold, P (1992) Glucose enhancement of memory in elderly humans: an inverted-U dose–response curve. Neurobiol Aging 13, 401–404.
119 Vanhanen, M, Koivisto, K, Kuusisto, J, et al. (1998) Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 21, 398–402.
120 Lamport, DJ, Lawton, CL, Mansfield, MW, et al. (2009) Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review. Neurosci Biobehav Rev 33, 394–413.
121 Leibson, CL, Rocca, WA, Hanson, VA, et al. (1997) Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 145, 301–308.
122 Ott, A, Stolk, RP, Hofman, A, et al. (1996) Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 39, 1392–1397.
123 Ott, A, Stolk, RP, Van Harskamp, F, et al. (1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53, 1937–1942.
124 Korhonen, H & Pihlanto, A (2007) Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Curr Pharm Des 13, 829–843.
125 Skov, A, Toubro, S, Rønn, B, et al. (1999) Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes 23, 528–536.
126 Crovetti, R, Porrini, M, Santangelo, A, et al. (1998) The influence of thermic effect of food on satiety. Eur J Clin Nutr 52, 482–488.
127 Westerterp-Plantenga, MS, Nieuwenhuizen, A, Tomé, D, et al. (2009) Dietary protein, weight loss, and weight maintenance. Annu Rev Nutr 29, 21–41.
128 Zemel, MB (2009) Proposed role of calcium and dairy food components in weight management and metabolic health. Phys Sportsmed 37, 29–39.
129 Belobrajdic, D, McIntosh, G & Owens, J (2003) Whey proteins protect more than red meat against azoxymethane induced ACF in Wistar rats. Cancer Lett 198, 43–51.
130 Badger, T, Ronis, M & Hakkak, R (2001) Developmental effects and health aspects of soy protein isolate, casein, and whey in male and female rats. Int J Toxicol 20, 165–174.
131 Hays, NP, Kim, H, Wells, AM, et al. (2009) Effects of whey and fortified collagen hydrolysate protein supplements on nitrogen balance and body composition in older women. J Am Diet Assoc 109, 1082–1087.
132 O'Rourke, RW (2009) Molecular mechanisms of obesity and diabetes: at the intersection of weight regulation, inflammation, and glucose homeostasis. World J Surg 33, 2007–2013.
133 Belobrajdic, D, McIntosh, G & Owens, J (2004) A high-whey-protein diet reduces body weight gain and alters insulin sensitivity relative to red meat in Wistar rats. J Nutr 134, 1454–1458.
134 Craft, S, Newcomer, J, Kanne, S, et al. (1996) Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 17, 123–130.
135 Gasparini, L, Gouras, GK, Wang, R, et al. (2001) Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 21, 2561–2570.
136 Kurochkin, IV & Goto, S (1994) Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 345, 33–37.
137 Qiu, WQ, Walsh, DM, Ye, Z, et al. (1998) Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J Biol Chem 273, 32730–32738.
138 Schwartz, MW, Figlewicz, DF, Kahn, SE, et al. (1990) Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats. Peptides 11, 467–472.
139 Gerozissis, K, Orosco, M, Rouch, C, et al. (1993) Basal and hyperinsulinemia-induced immunoreactive hypothalamic insulin changes in lean and genetically obese Zucker rats revealed by microdialysis. Brain Res 611, 258–263.
140 Hoyer, S (2002) The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. J Neural Transm 109, 991–1002.
141 Hong, M & Lee, VMY (1954) Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272, 19547–19553.
142 Sabayan, B, Foroughinia, F, Mowla, A, et al. (2008) Role of insulin metabolism disturbances in the development of Alzheimer disease: mini review. Am J Alzheimer's Dis Other Demen 23, 192–199.
143 Fishel, MA, Watson, GS, Montine, TJ, et al. (2005) Hyperinsulinemia provokes synchronous increases in central inflammation and β-amyloid in normal adults. Arch Neurol 62, 1539–1544.
144 Facchini, FS, Hua, NW, Reaven, GM, et al. (2000) Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? Free Radic Biol Med 29, 1302–1306.
145 Östman, EM, Liljeberg Elmståhl, HGM & Björck, IME (2001) Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. Am J Clin Nutr 74, 96–100.
146 Frid, AH, Nilsson, M, Holst, JJ, et al. (2005) Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr 82, 69–75.
147 Boirie, Y, Dangin, M, Gachon, P, et al. (1997) Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc Natl Acad Sci U S A 94, 14930–14935.
148 Floyd, JC Jr, Fajans, SS, Conn, JW, et al. (1966) Stimulation of insulin secretion by amino acids. J Clin Invest 45, 1487–1502.
149 Nilsson, M, Holst, JJ & Björck, IME (2007) Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am J Clin Nutr 85, 996–1004.
150 Fonseca, V (2003) Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus. Curr Med Res Opin 19, 635–641.
152 Kitts, DD & Weiler, K (2003) Bioactive proteins and peptides from food sources. Applications of bioprocess used in isolation and recovery. Curr Pharm Des 9, 1309–1323.
153 Nakamura, H, Iwamoto, M, Ogata, T, et al. (2008) Effects of milk casein-derived peptides on absolute oxyhaemoglobin concentrations in the prefrontal area and on work efficiency after mental stress loading in male students. J Int Med Res 36, 638–647.
154 Korhonen, H & Pihlanto, A (2006) Bioactive peptides: production and functionality. Int Dairy J 16, 945–960.
155 Korhonen, H (2009) Milk-derived bioactive peptides: from science to applications. J Funct Foods 1, 177–187.
156 Donkor, ON, Henriksson, A, Vasiljevic, T, et al. (2007) Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of growth and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk. Lait 87, 21–38.
157 Murray, BA & FitzGerald, RJ (2007) Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Curr Pharm Des 13, 773–791.
158 Clare, DA & Swaisgood, HE (2000) Bioactive milk peptides: a prospectus. J Dairy Sci 83, 1187–1195.
159 Meisel, H, Goepfert, A & Günther, S (1997) ACE-inhibitory activities in milk products. Milchwissenschaft 52, 307–311.
160 Smacchi, E & Gobbetti, M (1998) Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme. Enzyme Microb Technol 22, 687–694.
161 Saito, T, Nakamura, T, Kitazawa, H, et al. (2000) Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. J Dairy Sci 83, 1434–1440.
162 Teschemacher, H, Koch, G & Brantl, V (1997) Milk protein-derived opioid receptor ligands. Biopolymers 43, 99–117.
163 Daniel, H, Vohwinkel, M & Rehner, G (1990) Effect of casein and β-casomorphins on gastrointestinal motility in rats. J Nutr 120, 252–257.
164 Sturner, RA & Chang, KJ (1988) Opioid peptide content in infant formulas. Pediatr Res 23, 4–10.
165 Haque, E, Chand, R & Kapila, S (2009) Biofunctional properties of bioactive peptides of milk origin. Food Rev Int 25, 28–43.
166 Tidona, F, Criscione, A, Guastella, AM, et al. (2009) Peptidi bioattivi nei prodotti lattiero-caseari (Bioactive peptides in dairy products). Ital J Anim Sci 8, 315–340.
167 Pihlanto, A (2006) Antioxidative peptides derived from milk proteins. Int Dairy J 16, 1306–1314.
168 Zommara, MA, Toubo, H & Imaizumi, K (2002) Supplementing bovine milk immunoglobulin G prevents rats fed on a vitamin E-deficient diet from developing peroxidation stress. Ann Nutr Metab 46, 97–102.
169 Kullisaar, T, Songisepp, E, Mikelsaar, M, et al. (2003) Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Br J Nutr 90, 449–456.
170 Zemel, MB, Sun, X, Sobhani, T, et al. (2010) Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects. Am J Clin Nutr 91, 16–22.
171 Sekiya, S, Kobayashi, Y, Kita, E, et al. (1992) Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. J Jpn Soc Nutr Food Sci 45, 513–517.
172 Hata, Y, Yamamoto, M, Ohni, M, et al. (1996) A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 64, 767–771.
173 Seppo, L, Jauhiainen, T, Poussa, T, et al. (2003) A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 77, 326–330.
174 Seppo, L, Kerojoki, O, Suomalainen, T, et al. (2002) The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension – a pilot study on humans. Milchwissenschaft 57, 124–127.
175 Mizushima, S, Ohshige, K, Watanabe, J, et al. (2004) Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens 17, 701–706.
176 Hatakeyama, E, Yamaguchi, M, Muramoto, K, et al. (2003) Modulating effects of soy protein isolate and soy protein hydrolysate on human brain function. Soy Protein Res Jpn 6, 147–152.
177 Williamson, MP (1994) The structure and function of proline-rich regions in proteins. Biochem J 297, 249–260.
178 Boldogh, I & Kruzel, ML (2008) Colostrinin(TM): an oxidative stress modulator for prevention and treatment of age-related disorders. J Alzheimer's Dis 13, 303–321.
179 Kruzel, ML, Polanowski, A, Wilusz, T, et al. (2004) The alcohol-induced conformational changes in casein micelles: a new challenge for the purification of Colostrinin. Protein J 23, 127–133.
180 Janusz, M, Inglot, AD, Lisowski, J, et al. (1996) Colostrinin identified as new cytokine. Eur Cytokine Netw 7, 512.
181 Gladkevich, A, Bosker, F, Korf, J, et al. (2007) Proline-rich polypeptides in Alzheimer's disease and neurodegenerative disorders – therapeutic potential or a mirage? Prog Neuropsychopharmacology Biol Psychiatry 31, 1347–1355.
182 Janusz, M, Staroscik, K, Zimecki, M, et al. (1981) Chemical and physical characterization of a proline-rich polypeptide from sheep colostrum. Biochem J 199, 9–15.
183 Zabłocka, A, Janusz, M, Macała, J, et al. (2005) A proline-rich polypeptide complex and its nonapeptide fragment inhibit nitric oxide production induced in mice. Regul Peptides 125, 35–39.
184 Popik, P, Bobula, B, Janusz, M, et al. (1999) Colostrinin, a polypeptide isolated from early milk, facilitates learning and memory in rats. Pharmacol Biochem Behav 64, 183–189.
185 Leszek, J, Inglot, AD, Janusz, M, et al. (1999) Colostrinin®: a proline-rich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Arch Immunol Ther Exp 47, 377–385.
186 Bilikiewicz, A & Gaus, W (2004) Colostrinin (a naturally occuring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease. J Alzheimer's Dis 6, 17–26.
187 Swaisgood, H (1995) Nitrogenous components of milk. In Handbook of Milk Composition, p. 465 .
188 Montagne, P, Cuilliere, ML, Mole, C, et al. (1999) Immunological and nutritional composition of human milk in relation to prematurity and mothers' parity during the first 2 weeks of lactation. J Pediatr Gastroenterol Nutr 29, 75–80.
189 Chatterton, DEW, Smithers, G, Roupas, P, et al. (2006) Bioactivity of beta-lactoglobulin and alpha-lactalbumin – technological implications for processing. Int Dairy J 16, 1229–1240.
190 Heine, W, Radke, M, Wutzke, K, et al. (1996) Lactalbumin-enriched low-protein infant formulas: a comparison to breast milk feeding. Acta Paediatrica 85, 1024–1028.
191 Lehnert, H & Wurtman, RJ (1993) Amino acid control of neurotransmitter synthesis and release: physiological and clinical implications. Psychother Psychosom 60, 18–32.
192 Markus, C, Olivier, B, Panhuysen, G, et al. (2000) The bovine protein alpha-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress. Am J Clin Nutr 71, 1536–1544.
193 Markus, C, Jonkman, L, Lammers, J, et al. (2005) Evening intake of alpha-lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. Am J Clin Nutr 81, 1026–1033.
194 Orosco, M, Rouch, C, Beslot, F, et al. (2004) Alpha-lactalbumin-enriched diets enhance serotonin release and induce anxiolytic and rewarding effects in the rat. Behav Brain Res 148, 1–10.
195 Jacobs, BL, Van Praag, H & Gage, FH (2000) Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatr 5, 262–269.
196 Jouvet, M (1999) Sleep and serotonin: an unfinished story. Neuropsychopharmacology (New York, NY) 21, 24–27.
197 Minet-Ringuet, J, Le Ruyet, P, Tome, D, et al. (2004) A tryptophan-rich protein diet efficiently restores sleep after food deprivation in the rat. Behav Brain Res 152, 335–340.
198 Markus, C, Olivier, B, Panhuysen, G, et al. (2000) The bovine protein alpha-lactalbumin increases the plasma Trp/LNAA ratio, and in vulnerable subjects raises brain serotonin activity and decreases cortisol and mood under stress. Am J Clin Nutr 71, 1536–1544.
199 Markus, CR, Olivier, B & De Haan, EHF (2002) Whey protein rich in alpha-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. Am J Clin Nutr 75, 1051–1056.
200 Schmitt, J, Jorissen, B, Dye, L, et al. (2005) Memory function in women with premenstrual complaints and the effect of serotonergic stimulation by acute administration of an alpha-lactalbumin protein. J Psychopharmacol 19, 375–384.
201 Vaswani, M, Linda, F & Ramesh, S (2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27, 85–102.
202 Booij, L, Van der Does, A & Riedel, W (2003) Monoamine depletion in psychiatric and healthy populations: review. Mol Psychiatry 8, 951–973.
203 Merens, W, Booij, L, Markus, R, et al. (2007) The effects of a diet enriched with alpha-lactalbumin on mood and cortisol response in unmedicated recovered depressed subjects and controls. Br J Nutr 94, 415–422.
204 Booij, L, Merens, W, Markus, C, et al. (2006) Diet rich in alpha-lactalbumin improves memory in unmedicated recovered depressed patients and matched controls. J Psychopharmacol 20, 526–535.
205 Verschoor, E, Finlayson, G, Blundell, J, et al. (2010) Effects of an acute alpha-lactalbumin manipulation on mood and food hedonics in high- and low-trait anxiety individuals. Br J Nutr 104, 595–602.
206 US Department of Agriculture (2003) .
207 Clarke, R (2008) B-vitamins and prevention of dementia. Proc Nutr Soc 67, 75–81.
208 Vogel, T, Dali-Youcef, N, Kaltenbach, G, et al. (2009) Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature. Int J Clin Practice 63, 1061–1067.
209 Wang, HX, Wahlin, Ã, Basun, H, et al. (2001) Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 56, 1188–1194.
210 Nilsson, K, Gustafson, L, Faldt, R, et al. (1996) Hyperhomocysteinaemia – a common finding in a psychogeriatric population. Eur J Clin Invest 26, 853–859.
211 Nilsson, K, Gustafson, L & Hultberg, B (2001) Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 16, 609–614.
212 Miller, AL (2003) The methionine–homocysteine cycle and its effects on cognitive diseases. Altern Med Rev 8, 7–19.
213 West, RL, Lee, JM & Maroun, LE (1995) Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient. J Mol Neurosci 6, 141–146.
214 Rogaev, EI, Lukiw, WJ, Lavrushina, O, et al. (1994) The upstream promoter of the Î2-amyloid precursor protein gene (APP) shows differential patterns of methylation in human brain. Genomics 22, 340–347.
215 Kruman, II, Culmsee, C, Chan, SL, et al. (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20, 6920–6926.
216 Ho, PI, Collins, SC, Dhitavat, S, et al. (2001) Homocysteine potentiates Î2-amyloid neurotoxicity: role of oxidative stress. J Neurochem 78, 249–253.
217 Elias, MF, Sullivan, LM, D'Agostino, RB, et al. (2005) Homocysteine and cognitive performance in the Framingham Offspring Study: age is important. Am J Epidemiol 162, 644–653.
218 Clarke, R, Smith, AD, Jobst, KA, et al. (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55, 1449–1455.
219 Joosten, E, Lesaffre, E, Riezler, R, et al. (1997) Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol A Biol Sci Med Sci 52, M76–M79.
220 US Department of Health and Human Services & US Department of Agriculture (2005) Dietary Guidelines for Americans, 6th ed. Washington, DC: US Government. http://www.health.gov/dietaryguidelines.
221 Gao, X, Wilde, PE, Lichtenstein, AH, et al. (2006) Meeting adequate intake for dietary calcium without dairy foods in adolescents aged 9 to 18 years (National Health and Nutrition Examination Survey 2001–2002). J Am Diet Assoc 106, 1759–1765.
222 Astrup, A, Chaput, JP, Gilbert, JA, et al. (2010) Dairy beverages and energy balance. Physiol Behav 100, 67–75.
223 Major, GC, Chaput, JP, Ledoux, M, et al. (2008) Recent developments in calcium-related obesity research. Obes Rev 9, 428–445.
224 Govers, MJAP, Termont, DSML, Van Aken, GA, et al. (1994) Characterization of the adsorption of conjugated and unconjugated bile acids to insoluble, amorphous calcium phosphate. J Lipid Res 35, 741–748.
225 Gacs, G & Barltrop, D (1977) Significance of Ca soap formation for calcium absorption in the rat. Gut 18, 64–68.
226 Ditscheid, B, Keller, S & Jahreis, G (2005) Cholesterol metabolism is affected by calcium phosphate supplementation in humans. J Nutr 135, 1678–1682.
227 Payne, ME, Anderson, JJB & Steffens, DC (2008) Calcium and vitamin D intakes may be positively associated with brain lesions in depressed and nondepressed elders. Nutr Res 28, 285–292.
228 Bolland, MJ, Barber, PA, Doughty, RN, et al. (2008) Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336, 262–266.
229 Daly, R, Ebeling, P, Khan, B, et al. (2009) Effect of calcium–vitamin D3 fortified milk on abdominal aortic calcification in older men: retrospective analysis of a 2-year randomized controlled trial. J Bone Miner Res 24, 1215.
230 Thibault, O, Gant, JC & Landfield, W (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 6, 307–317.
231 Levy, J, Gavin, JR 3rd & Sowers, JR (1994) Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 96, 260–273.
232 Stutzmann, GE, Smith, I, Caccamo, A, et al. (2006) Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. J Neurosci 26, 5180–5189.
233 Potier, B, Rascol, O, Jazat, F, et al. (1992) Alterations in the properties of hippocampal pyramidal neurons in the aged rat. Neuroscience 48, 793–806.
234 Landfield, PW & Pitler, TA (1984) Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats. Science 226, 1089–1092.
235 Kerr, DS, Campbell, LW, Hao, SY, et al. (1989) Corticosteroid modulation of hippocampal potentials: increased effect with aging. Science 245, 1505–1509.
236 Moyer, JR Jr, Thompson, LT, Black, JP, et al. (1992) Nimodipine increases excitability of rabbit CA1 pyramidal neurons in an age- and concentration-dependent manner. J Neurophysiol 68, 2100–2109.
237 Disterhoft, JF, Thompson, LT, Moyer, JR Jr, et al. (1996) Calcium-dependent afterhyperpolarization and learning in young and aging hippocampus. Life Sci 59, 413–420.
238 Hemond, P & Jaffe, DB (2005) Caloric restriction prevents aging-associated changes in spike-mediated Ca2+ accumulation and the slow afterhyperpolarization in hippocampal CA1 pyramidal neurons. Neuroscience 135, 413–420.
239 Thibault, O, Hadley, R & Landfield, PW (2001) Elevated postsynaptic [Ca2+]i and L-type calcium channel activity in aged hippocampal neurons: relationship to impaired synaptic plasticity. J Neurosci 21, 9744–9756.
240 Campbell, LW, Hao, SY, Thibault, O, et al. (1996) Aging changes in voltage-gated calcium currents in hippocampal CA1 neurons. J Neurosci 16, 6286–6295.
241 Thibault, O & Landfield, PW (1996) Increase in single L-type calcium channels in hippocampal neurons during aging. Science 272, 1017–1020.
242 Smith, IF, Hitt, B, Green, KN, et al. (2005) Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease. J Neurochem 94, 1711–1718.
243 Kopp-Hoolihan, L (2001) Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 101, 229–241.
244 Butt, H, Dunstan, R & McGregor, N, et al. (2001) .
245 Logan, A & Katzman, M (2005) Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses 64, 533–538.
246 Desbonnet, L, Garrett, L, Clarke, G, et al. (2008) The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 43, 164–174.
247 Benton, D, Williams, C & Brown, A (2007) Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 61, 355–361.
248 Lomer, MCE, Parkes, GC & Sanderson, JD (2008) Review Article: lactose intolerance in clinical practice – myths and realities. Aliment Pharmacol Ther 27, 93–103.